Category: Beta Cell Physiology and Dysfunction

IGF receptor-like 1 and 2, new therapeutic targets for increasing insulin sensitivity and beta cell health

Diabetes mellitus is a complex and multifactorial disease characterized by progressive loss or dysfunction of the insulin-producing beta cells in the pancreas. This results in chronic hyperglycemia and systemic metabolic complications and, in the long-term, in multi-organ damages; together, these complications create enormous medical and social burdens as well as causing premature deaths. Today, over […]